Neuroprotective effect of α‐mangostin in the ameliorating propionic acid‐induced experimental model of autism in wistar rats

Several studies have documented the role of hyper‐activation of extracellular signal‐reg-ulated kinases (ERK) in Autism pathogenesis. Alpha‐mangostin (AMG) is a phytoconstituents with anti‐oxidants, anti‐inflammatory, and ERK inhibition properties in many diseases. Our research aims to investigate the neuroprotective effect of AMG in the rat model of intracerebroventricular-propionic acid (ICV‐PPA) induced autism with a confirmation of its effect on the ERK signaling. Autism was induced in Wistar rats (total 36 rats; 18 male/18 female) by multiple doses of PPA through ICV injection for 11 days. Actophotometer and beam walking tasks were used to evaluate animalsʹ motor abilities, and the Morris water maze task was utilized to confirm the cognition and memory in animals. Long term administration of AMG 100 mg/kg and AMG 200mg/kg continued from day 12 to day 44 of the experiment. Before that, animals were sacrificed, brains isolated, mor-phological, gross pathological studies were performed, and neurochemical analysis was performed in the brain homogenates. Cellular and molecular markers, including ERK, myelin basic protein, apoptotic markers including caspase‐3, Bax, Bcl‐2, neuroinflammatory markers, neurotransmitters, and oxidative stress markers, have been tested throughout the brain. Thus, AMG reduces the over-activation of the ERK signaling and also restored autism‐like behavioral and neurochemical altera-tions.